AAAAAA

   
Results: 1-8 |
Results: 8
Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study
Authors: Dinan, TG Scott, LV Thakore, J Naesdal, J Keeling, PWN
Citation: Tg. Dinan et al., Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study, PSYCHONEURO, 26(7), 2001, pp. 751-756
A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia - are central serotoninergic responses enhanced?
Authors: Dinan, TG Mahmud, N Rathore, O Thakore, J Scott, LV Carr, E Naesdal, J O'Morain, CA Keeling, PWN
Citation: Tg. Dinan et al., A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia - are central serotoninergic responses enhanced?, ALIM PHARM, 15(10), 2001, pp. 1613-1618
Diagnostic and therapeutic ERCP: a large single centre's experience
Authors: Farrell, RJ Mahmud, N Noonan, N Kelleher, D Keeling, PWN
Citation: Rj. Farrell et al., Diagnostic and therapeutic ERCP: a large single centre's experience, IRISH J MED, 170(3), 2001, pp. 176-180
Potential impact of magnetic resonance cholangiopancreatography on endoscopic retrograde cholangiopancreatography workload and complication rate in patients referred because of abdominal pain
Authors: Farrell, RJ Noonan, N Mahmud, N Morrin, MM Kelleher, D Keeling, PWN
Citation: Rj. Farrell et al., Potential impact of magnetic resonance cholangiopancreatography on endoscopic retrograde cholangiopancreatography workload and complication rate in patients referred because of abdominal pain, ENDOSCOPY, 33(8), 2001, pp. 668-675
Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease
Authors: Ang, YS Mahmud, N White, B Byrne, M Kelly, A Lawler, M McDonald, GSA Smith, OP Keeling, PWN
Citation: Ys. Ang et al., Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease, ALIM PHARM, 14(8), 2000, pp. 1015-1022
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low
Authors: Farrell, RJ Ang, Y Kileen, P O'Briain, DS Kelleher, D Keeling, PWN Weir, DG
Citation: Rj. Farrell et al., Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low, GUT, 47(4), 2000, pp. 514-519
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy
Authors: Farrell, RJ Murphy, A Long, A Donnelly, S Cherikuri, A O'Toole, D Mahmud, N Keeling, PWN Weir, DG Kelleher, D
Citation: Rj. Farrell et al., High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy, GASTROENTY, 118(2), 2000, pp. 279-288
Heparin and inflammatory bowel disease
Authors: White, B Ang, YS Mahmud, N Keeling, PWN Smith, OP
Citation: B. White et al., Heparin and inflammatory bowel disease, LANCET, 354(9184), 1999, pp. 1122-1123
Risultati: 1-8 |